Argenica Therapeutics Ltd News

Argenica Therapeutics Ltd: Positive Results in Key IND Enabling Studies

Sep 24 19:40 ET

Argenica Therapeutics Ltd: Application for quotation of securities - AGN

Sep 23 19:00 ET

Argenica Therapeutics Ltd: Initial Director's Interest Notice x2

Sep 16 18:20 ET

Argenica Therapeutics Ltd: New Appointments to the Board of Directors

Sep 16 18:20 ET

Argenica Therapeutics Ltd: Date of AGM & Closing Date For Director Nominations

Sep 16 18:19 ET

Argenica Therapeutics Ltd: Positive DSMB Safety Outcome & Phase 2 Trial Progress Update

Sep 5 18:55 ET

Argenica Therapeutics Ltd: Appendix 4G & Corporate Governance Statement

Aug 28 03:18 ET

Argenica Therapeutics Ltd: Appendix 4E & Annual Report to 30 June 2024

Aug 28 03:16 ET

Argenica Therapeutics Ltd: Change of Director's Interest Notice

Aug 14 02:22 ET

Argenica Therapeutics Ltd: Notification regarding unquoted securities - AGN

Aug 14 02:19 ET

Argenica Therapeutics Ltd: Results of Meeting

Aug 13 21:43 ET

Argenica Therapeutics Ltd: Change of Director's Interest Notice x3

Aug 7 18:28 ET

Argenica Therapeutics Ltd: Cleansing Notice

Aug 7 18:28 ET

Argenica Therapeutics Ltd: Notification of cessation of securities - AGN

Aug 7 18:28 ET

Argenica Therapeutics Ltd: Application for quotation of securities - AGN

Aug 7 18:27 ET

Argenica Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 30 20:29 ET

Argenica Therapeutics Ltd: Phase 2 Stroke Clinical Trial Update

Jul 23 18:16 ET

Argenica Therapeutics Ltd: Investor Webinar Presentation

Jul 21 18:14 ET

Argenica Therapeutics Ltd: Investor Presentation

Jul 14 18:27 ET

Argenica Therapeutics Ltd: Notice of General Meeting/Proxy Form

Jul 11 18:23 ET